Literature DB >> 1441508

Diffuse demyelinating lesions of the brain after the rapid development of hypernatremia.

W R Clark1.   

Abstract

Entities:  

Mesh:

Year:  1992        PMID: 1441508      PMCID: PMC1022047     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  11 in total

1.  Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients.

Authors:  R D ADAMS; M VICTOR; E L MANCALL
Journal:  AMA Arch Neurol Psychiatry       Date:  1959-02

2.  Hypernatremia after the administration of lactulose.

Authors:  C Kaupke; T Sprague; G L Gitnick
Journal:  Ann Intern Med       Date:  1977-06       Impact factor: 25.391

3.  Central pontine myelinolysis associated with acute haemorrhagic pancreatitis.

Authors:  R J Sherins; M A Verity
Journal:  J Neurol Neurosurg Psychiatry       Date:  1968-12       Impact factor: 10.154

Review 4.  Treatment of symptomatic hyponatremia and its relation to brain damage. A prospective study.

Authors:  J C Ayus; R K Krothapalli; A I Arieff
Journal:  N Engl J Med       Date:  1987-11-05       Impact factor: 91.245

5.  Association between rise in serum sodium and central pontine myelinolysis.

Authors:  M D Norenberg; K O Leslie; A S Robertson
Journal:  Ann Neurol       Date:  1982-02       Impact factor: 10.422

6.  Pontine and extrapontine myelinolysis following liver transplantation. Relationship to serum sodium.

Authors:  Z K Wszolek; R D McComb; R F Pfeiffer; R E Steg; R P Wood; B W Shaw; R S Markin
Journal:  Transplantation       Date:  1989-12       Impact factor: 4.939

7.  Changing concepts in treatment of severe symptomatic hyponatremia. Rapid correction and possible relation to central pontine myelinolysis.

Authors:  J C Ayus; R K Krothapalli; A I Arieff
Journal:  Am J Med       Date:  1985-06       Impact factor: 4.965

8.  Hypernatremia in hepatic failure.

Authors:  S E Warren; J A Mitas; A H Swerdlin
Journal:  JAMA       Date:  1980-03-28       Impact factor: 56.272

9.  Osmotic demyelination syndrome following correction of hyponatremia.

Authors:  R H Sterns; J E Riggs; S S Schochet
Journal:  N Engl J Med       Date:  1986-06-12       Impact factor: 91.245

10.  Central pontine myelinolysis in severely burned patients: relationship to serum hyperosmolality.

Authors:  A C McKee; M D Winkelman; B Q Banker
Journal:  Neurology       Date:  1988-08       Impact factor: 9.910

View more
  7 in total

1.  Osmotic shifts, metabolic compromise, and the vulnerability of the pons.

Authors:  A C McKee
Journal:  West J Med       Date:  1992-11

Review 2.  Clinical semiology and neuroradiologic correlates of acute hypernatremic osmotic challenge in adults: a literature review.

Authors:  F Y Ismail; A Szóllics; M Szólics; N Nagelkerke; M Ljubisavljevic
Journal:  AJNR Am J Neuroradiol       Date:  2013-02-14       Impact factor: 3.825

3.  Osmotic Demyelination Syndrome Associated with Hypernatremia Caused by Lactulose Enema in a Patient with Chronic Alcoholism.

Authors:  Jeong Ho Lee; Chang Seong Kim; Eun Hui Bae; Soo Wan Kim; Seong Kwon Ma
Journal:  Electrolyte Blood Press       Date:  2021-06-30

Review 4.  Preventing neurological complications from dysnatremias in children.

Authors:  Michael L Moritz; J Carlos Ayus
Journal:  Pediatr Nephrol       Date:  2005-08-04       Impact factor: 3.714

5.  Effects of hypernatraemia in the central nervous system and its therapy in rats and rabbits.

Authors:  J C Ayus; D L Armstrong; A I Arieff
Journal:  J Physiol       Date:  1996-04-01       Impact factor: 5.182

6.  Can osmotic demyelination syndrome be a complication of liver failure?

Authors:  Kaylynn Purdy; Dustin Anderson; Richard Camicioli; Rachel G Khadaroo
Journal:  eNeurologicalSci       Date:  2020-01-27

7.  Plasma exchange successfully treats central pontine myelinolysis after acute hypernatremia from intravenous sodium bicarbonate therapy.

Authors:  Kyung Yoon Chang; In-Hee Lee; Gi Jun Kim; Kangwon Cho; Hoon Suk Park; Hyung Wook Kim
Journal:  BMC Nephrol       Date:  2014-04-04       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.